We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti-platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti-malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, anti-fungal, anti-inflammatory/analgesic/anti-pyretic, anti-diabetic, cardiac, vitamins, topical steroids/corticosteroids, and other formulations. In addition, it offers veterinary pharmaceutical, nutraceutical, oncology, herbal, and surgical products. The company was founded in 1989 and is headquartered in Mumbai, India.
TODAY'S HIGH
83.9
TODAY'S LOW
81.5
52 WEEK HIGH
119.3
52 WEEK LOW
28.95
% of Shares Held by
All Insider
nan
% of Shares Held by
Institutions
nan
% of Float Held by
Institutions
nan
Number of Institutions
Holding Shares
nan
MARKET CAP
86.95 Cr.
ETERPRISE VALUE
107.24 Cr.
NO. OF SHARES
1.05 Cr.
BOOK VALUE
24.691
DIV. YIELD
None%
DEBT
20.81 Cr.
GROSS PROFIT
12.32 Cr.
CASH
1.35 Cr.
REVENUE
75.82 Cr.
REVENUE/SHARE
71.984
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Investments | 0 | 0 | 0 | 0 |
| Change To Liabilities | -12.10 Cr. | 17.05 Cr. | -89.32 Lakhs | 2.14 Cr. |
| Total cashflows from Investing Activities | -84.68 Lakhs | -11.03 Lakhs | -1.93 Lakhs | -28.45 Lakhs |
| Net Borrowings | 2.96 Cr. | 80.54 Lakhs | -60.99 Lakhs | -1.31 Cr. |
| Total Cash from Financing Activities | 41.76 Lakhs | -1.81 Cr. | -3.13 Cr. | -3.99 Cr. |
| Other Liabilities | -1.22 Cr. | 1.39 Cr. | -7.81 Lakhs | 3.42 Cr. |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | 4.02 Cr. | 1.04 Cr. | 3.27 Lakhs | 71.35 Lakhs |
| Change in Cash | 88.93 Lakhs | 8.91 Lakhs | 6.05 Lakhs | 3.59 Lakhs |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | 1.31 Cr. | 2.01 Cr. | 3.21 Cr. | 4.31 Cr. |
| Depreciation | 45.63 Lakhs | 42.43 Lakhs | 43.67 Lakhs | 26.56 Lakhs |
| Other Cashflows from Investing Activities | 1.80 Lakhs | 1.56 Lakhs | 3.32 Lakhs | 1.17 Lakhs |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Change to Inventory | -4.07 Lakhs | 29.18 Lakhs | 10.12 Lakhs | 88.67 Lakhs |
| Change to Account Receivables | 8.22 Cr. | -21.52 Cr. | -1.04 Cr. | -4.84 Cr. |
| Other Cashflows from Financing Activities | -2.54 Cr. | -2.61 Cr. | -2.52 Cr. | -2.67 Cr. |
| Change to Net Income | 1.99 Cr. | 3.31 Cr. | 4.66 Cr. | 1.71 Cr. |
| Capital Expenditures | -86.48 Lakhs | -12.60 Lakhs | -5.26 Lakhs | -29.62 Lakhs |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 5.72 Cr. | 1.40 Cr. | 7.91 Lakhs | 1.13 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 6.39 Cr. | 2.22 Cr. | 46.28 Lakhs | 1.81 Cr. |
| Selling General Administrative | 2.09 Cr. | 1.93 Cr. | 2.20 Cr. | 2.64 Cr. |
| Gross Profit | 12.32 Cr. | 7.60 Cr. | 8.97 Cr. | 6.39 Cr. |
| Ebit | 6.39 Cr. | 2.22 Cr. | 46.28 Lakhs | 1.81 Cr. |
| Operating Income | 6.39 Cr. | 2.22 Cr. | 46.28 Lakhs | 1.81 Cr. |
| Other Operating Expenses | 3.36 Cr. | 1.19 Cr. | 2.40 Cr. | 1.67 Cr. |
| Interest Expense | -2.45 Cr. | -2.62 Cr. | -2.55 Cr. | -2.66 Cr. |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 1.70 Cr. | 35.82 Lakhs | 4.63 Lakhs | 41.88 Lakhs |
| Total Revenue | 75.82 Cr. | 53.77 Cr. | 60.08 Cr. | 75.09 Cr. |
| Total Operating Expenses | 69.42 Cr. | 51.55 Cr. | 59.62 Cr. | 73.27 Cr. |
| Cost of Revenue | 63.50 Cr. | 46.16 Cr. | 51.10 Cr. | 68.69 Cr. |
| Total Other Income Expense Net | -67.07 Lakhs | -81.65 Lakhs | -38.37 Lakhs | -67.95 Lakhs |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 4.02 Cr. | 1.04 Cr. | 3.27 Lakhs | 71.35 Lakhs |
| Net Income Applicable to Common Shares | 4.02 Cr. | 1.04 Cr. | 3.27 Lakhs | 71.35 Lakhs |
| Particulars | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|
| Intangible Assets | 76.92 Lakhs | 29.35 Lakhs | 39.67 Lakhs | 49.48 Lakhs |
| Capital Surplus | 0 | 8.20 Cr. | 8.20 Cr. | 12.19 Cr. |
| Total Liabilities | 55.26 Cr. | 63.70 Cr. | 44.82 Cr. | 47.35 Cr. |
| Stock Holder Equity | 26.35 Cr. | 22.41 Cr. | 21.38 Cr. | 21.39 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 5.28 Cr. | 2.48 Cr. | 1.86 Cr. | 3.02 Cr. |
| Total Assets | 81.62 Cr. | 86.12 Cr. | 66.20 Cr. | 68.75 Cr. |
| Common Stock | 10.54 Cr. | 10.54 Cr. | 10.54 Cr. | 6.59 Cr. |
| Retained Earnings | 0 | 3.56 Cr. | 2.51 Cr. | 2.48 Cr. |
| Other Liabilities | 18.92 Lakhs | 18.49 Lakhs | 13.88 Lakhs | 9.41 Lakhs |
| Good Will | 0 | 0 | 0 | 0 |
| Treasury Stock | 15.80 Cr. | 10.50 Lakhs | 11.41 Lakhs | 12.64 Lakhs |
| Other Assets | 3.09 Cr. | 2.48 Cr. | 2.34 Cr. | 3.32 Cr. |
| Cash | 1.35 Cr. | 31.34 Lakhs | 28.32 Lakhs | 22.99 Lakhs |
| Current Liabilities | 51.93 Cr. | 59.26 Cr. | 40.41 Cr. | 42.47 Cr. |
| Long Term Asset Charges | 16.07 Lakhs | 14.80 Lakhs | 12.42 Lakhs | 10.96 Lakhs |
| Short Long Term Debt | 17.65 Cr. | 1.91 Cr. | 95.93 Lakhs | 84.67 Lakhs |
| Other Stockholder Equity | 15.80 Cr. | 10.50 Lakhs | 11.41 Lakhs | 12.64 Lakhs |
| Property Plant Equipment | 90.36 Lakhs | 97.06 Lakhs | 1.16 Cr. | 87.84 Lakhs |
| Total Cur. Assets | 76.42 Cr. | 81.29 Cr. | 61.20 Cr. | 62.97 Cr. |
| Long Term Investments | 43.15 Lakhs | 1.08 Cr. | 1.08 Cr. | 1.08 Cr. |
| Net Tangible Assets | 25.58 Cr. | 22.12 Cr. | 20.98 Cr. | 20.90 Cr. |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 58.50 Cr. | 67.21 Cr. | 47.25 Cr. | 49.85 Cr. |
| Long Term Debt | 3.10 Cr. | 4.03 Cr. | 4.05 Cr. | 4.77 Cr. |
| Inventory | 62.90 Lakhs | 58.82 Lakhs | 88 Lakhs | 98.12 Lakhs |
| Accounts Payable | 28.38 Cr. | 40.53 Cr. | 23.63 Cr. | 24.52 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account